SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Saflink Corp. (ESAF) Biometric Software Provider -- Ignore unavailable to you. Want to Upgrade?


To: brad greene who wrote (2639)1/15/1998 11:25:00 AM
From: GoingHikin  Read Replies (1) | Respond to of 4676
 
In the "3rd quarter answer's to shareholders questions" Mr. G mentions the Mayo Clinic as one of their developing healthcare contracts along with two or three others that have already been announced. Who knows what will happen if and when they announce, but it is promising!

-DL



To: brad greene who wrote (2639)1/16/1998 2:31:00 AM
From: Jaffo  Read Replies (1) | Respond to of 4676
 
Brad and to ALL:

With due respect, there is no need to confirm the 2,200 unit sale as that would be like having to confirm that a spade is a shovel. Wheather or not the sale was with Mayo is not a big issue even though I won't bet against it.

Further, my tea leafs tell me that two sales of 10,000 units each are under discussion/negotiation. One is with a European firm and the other is a mighty huge credit card company. May this reading come to pass in 1998. Of course, the sooner the better.

Regarding HAAPI, my s/w Guru and I have the same vision/speculation. He offered the following:

"I noticed that NRI will have these products embedded within the HAPPI
interface available for shipping in February. It is these three
products (plus all additional products to come from NRI which have
the HAPPI interface) which may be licenced by Microsoft. Basically, I
see the HAPPI technology and SAF product line as one combined
licence, where NRI receives a set price per Windows 98 or NT sold.
I could be wrong about only one licencing scheme, and we'll
have to see how it develops."

HAAPI 1998 everyone.

Jaffo...caveat emptor applies